Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines
- PMID: 15501982
- DOI: 10.1158/1078-0432.CCR-04-0879
Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines
Abstract
Purpose: The purpose of this study was to assess whether troglitazone (TRO) would induce cellular acidosis by inhibiting Na(+)/H(+) exchanger (NHE) 1 in breast carcinoma-derived cell lines and, if so, whether cellular acidosis would be associated with a reduction in proliferation.
Experimental design: Intracellular pH (pH(i)) and acid extrusion capacity after an exogenous acid load were assayed using (2, 7)-biscarboxyethyl-5(6)-carboxyfluorescein in MCF-7 and MDA-MB-231 cells treated with TRO. Radiolabeled thymidine incorporation was used to assess DNA synthesis. Peroxisome proliferator-activated receptor (PPAR) gamma involvement was assessed using an antagonist and PPARgamma(-/-) NIH3T3 cells.
Results: TRO induced a prompt (<4 minute) and severe cellular acidosis in both MCF-7 (7.54 +/- 0.23 to 6.77 +/- 0.06; P < 0.001) and MDA-MB-231 cells (7.38 +/- 0.18 to 6.89 +/- 0.25; P < 0.05) after 12 minutes, without increasing acid production. Acid extrusion as assessed by the response to an exogenous acid load (NH(4)Cl pulse) was markedly blunted (MDA-MB-231, P < 0.01) or eliminated (MCF-7, P < 0.001). Chronic exposure to TRO resulted in NHE1 activity reduction (P < 0.05) and a dose-dependent decrease in DNA synthesis (<75% inhibition at 100 micromol/L; P < 0.001 and P < 0.01 for MCF-7 and MDA-MB-231, respectively) associated with a decreased number of viable cells. TRO-mediated inhibition of proliferation was not reversed by the presence of the PPARgamma inhibitor GW9662 and was demonstrable in PPARgamma(-/-) NIH3T3 cells, consistent with a PPARgamma-independent mechanism.
Conclusions: TRO induces marked cellular acidosis in MCF-7 and MDA-MD-231 cells. Sustained acidosis is consonant with decreased proliferation and growth that is not reversed by a PPARgamma antagonist. Our results support a NHE-mediated action of TRO that exerts its effect independent of PPARgamma.
Similar articles
-
Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7.Cell Physiol Biochem. 2007;20(6):751-62. doi: 10.1159/000110435. Cell Physiol Biochem. 2007. PMID: 17982257
-
Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.Cell Biol Int. 2008 Aug;32(8):906-12. doi: 10.1016/j.cellbi.2008.04.011. Epub 2008 Apr 10. Cell Biol Int. 2008. PMID: 18474441
-
Troglitazone acts by PPARgamma and PPARgamma-independent pathways on LLC-PK1-F+ acid-base metabolism.Am J Physiol Renal Physiol. 2004 Jan;286(1):F100-10. doi: 10.1152/ajprenal.00182.2003. Epub 2003 Sep 23. Am J Physiol Renal Physiol. 2004. PMID: 14506076
-
Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.Endocr Relat Cancer. 2006 Jun;13(2):401-13. doi: 10.1677/erc.1.01182. Endocr Relat Cancer. 2006. PMID: 16728570 Review.
-
[Anti-cancer action by PPARgamma ligand].Nihon Rinsho. 2010 Feb;68(2):267-72. Nihon Rinsho. 2010. PMID: 20158095 Review. Japanese.
Cited by
-
A Green one-pot three component synthesis of thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidines with [Bmim]BF4: their in vitro and in silico anti-TB studies.Mol Divers. 2025 Feb;29(1):303-317. doi: 10.1007/s11030-024-10853-5. Epub 2024 May 24. Mol Divers. 2025. PMID: 38789853
-
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.Br J Cancer. 2007 Sep 3;97(5):646-53. doi: 10.1038/sj.bjc.6603922. Epub 2007 Aug 7. Br J Cancer. 2007. PMID: 17687336 Free PMC article.
-
Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.BMC Cancer. 2010 Jul 22;10:390. doi: 10.1186/1471-2407-10-390. BMC Cancer. 2010. PMID: 20650001 Free PMC article.
-
Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists.PPAR Res. 2008;2008:103167. doi: 10.1155/2008/103167. Epub 2009 Jan 28. PPAR Res. 2008. PMID: 19197366 Free PMC article.
-
Effect of troglitazone on radiation sensitivity in cervix cancer cells.Radiat Oncol J. 2012 Jun;30(2):78-87. doi: 10.3857/roj.2012.30.2.78. Epub 2012 Jun 30. Radiat Oncol J. 2012. PMID: 22984686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous